Comparison of the Cosmed K4 b(2) and the Deltatrac II metabolic cart in measuring resting energy expenditure in adults

BACKGROUND AND AIMS: The objective of the study was to compare data obtained from the Cosmed K4 b(2) and the Deltatrac II metabolic cart for the purpose of determining the validity of the Cosmed K4 b(2) in measuring resting energy expenditure. METHODS: Nine adult subjects (four male, five female) were measured. Resting energy expenditure was measured in consecutive sessions using the Cosmed K4 b(2), the Deltatrac II metabolic cart separately and the Cosmed K4 b(2) and Deltatrac II metabolic cart simultaneously, performed in random order. Resting energy expenditure (REE) data from both devices were then compared with values obtained from predictive equations. RESULTS: Bland and Altman analysis revealed a mean bias for the four variables, REE, respiratory quotient (RQ), V CO(2), V O(2) between data obtained from Cosmed K4 b(2) and Deltatrac II metabolic cart of 268+/-702 kcal/day, -0.0+/-0.2, 26.4+/-118.2 and 51.6+/-126.5 ml/min, respectively. Corresponding limits of agreement for the same four variables were all large. Also, Bland and Altman analysis revealed a larger mean bias between predicted REE and measured REE using Cosmed K4 b(2) data (-194+/-603 kcal/day) than using Deltatrac metabolic cart data (73+/-197 kcal/day). CONCLUSIONS: Variability between the two devices was very high and a degree of measurement error was detected. Data from the Cosmed K4 b(2) provided variable results on comparison with predicted values, thus, would seem an invalid device for measuring adults.     

Development of new generation influenza vaccines : Recipes for success?

As infectious diseases cause approximately 25% of the annual global mortality, vaccines are found to be a time proven and promising response to infectious disease need. However, like for pharmaceutical small molecules, vaccine development is lengthy, risky and resource demanding. Faced with an attrition rate estimated around 80%, key opinion leaders were interviewed with the question: is there a recipe for success?     

The changing of the guards : Can family doctors contain worker absenteeism?

Using administrative data from Norway, we examine the extent to which family doctors influence their clients’ propensity to claim sick-pay. The analysis exploits exogenous switches of family doctors occurring when physicians quit, retire, or for other reasons sell their patient lists. We find that family doctors have significant influence on their clients’ absence behavior, particularly on absence duration. Their influence is stronger in geographical areas with weaker competition between physicians. We conclude that it is possible for family doctors to contain sick-pay expenditures to some extent, and that there is a considerable variation in the way they perform this task.     

Le blues du mangeur: Comment manger sans pécher ?

For human consumers, eating means more than simply obtaining nutrients. Following millenaries of food shortages, the present-day plethora associated with industrialized and globalized production has changed the food situation and exposed human consumers to dangers for which they are not prepared, among which obesity is the most obvious. Food behavior and weight “norms” recommended by experts might have done more harm than good. A consequence of the restrictive diets proposed by medical dietetics for over half a century is “cognitive restraint”, which favors eating disorders as well as weight gain, and compromises the quality of life of obese individuals confronted by social stigma. Nutrition specialists who have remained aware of human heterogeneity and complexity, denied by the orthodox dogma supported by international medical dietetics, have proposed promising options for both treatment and prevention.     

Varying protein source and quantity do not significantly improve weight loss, fat loss, or satiety in reduced energy diets among midlife adults

We hypothesized that a whey protein diet would result in greater weight loss and improved body composition compared with standard weight loss diets. Weight change, body composition, and renin-angiotensin aldosterone system activity in midlife adults were compared between diet groups. Eighteen subjects enrolled in a 5-month study of 8-week controlled food intake followed by 12-weeks ad libitum intake. Subjects were randomized to 1 of 3 treatment groups: control diet (CD) (55% carbohydrate/15% protein/30% fat), mixed protein (40% carbohydrate/30% protein/30% fat), or whey protein (WP) (40% carbohydrate/15% mixed protein/15% whey protein/30% fat). Measurements included weight, metabolic measures, body composition by dual-energy x-ray absorptiometry, and resting energy expenditure. No statistically significant differences in total weight loss or total fat loss were observed between treatments; however, a trend toward greater total weight loss (P = .08) and total fat loss (P = .09) was observed in the WP group compared with the CD group. Fat loss in the leg and gynoid regions was greater (P < .05) in the WP group than the CD group. No renin-angiotensin aldosterone system-mediated response was observed, but a decrease in systolic blood pressure was significantly greater (P < .05) in the WP group compared with the CD group. In summary, increased whey protein intake did not result in statistically significant differences in weight loss or in total fat loss, but significant differences in regional fat loss and in decreased blood pressure were observed in the WP group.     

Mucosal application of cationic poly(d,l-lactide-co-glycolide) microparticles as carriers of DNA vaccine and adjuvants to protect chickens against infectious bursal disease

Infectious bursal disease virus (IBDV) is an immunosuppressive virus of chickens. The virus protein (VP) 2 induces neutralizing antibodies, which protect chickens against the disease. The aim of this study was to develop a cationic poly(d,l-lactide-co-glycolide) (PLGA) microparticle (MP) based IBDV-VP2 DNA vaccine (MP-IBDV-DNA) for chickens to be delivered orally and by eye drop route. The tested IBDV-VP2 DNA vaccines were immunogenic for specific-pathogen-free chickens and induced an antibody response after intramuscular application. Co-inoculation with a plasmid encoding chicken IL-2 (chIL-2) or CpG-ODN did not significantly improve protection against IBDV challenge. However, the application of a MP-IBDV-DNA vaccine alone or in combination with a delayed oral and eye drop application of cationic MP loaded with CpG-ODN or chIL-2 improved protection against challenge. The MP-IBDV-DNA-vaccinated chickens showed less pathological and histopathological bursal lesions, a reduced IBDV antigen load as well as T-cell influx into the bursa of Fabricius (BF) compared to the other groups (p < 0.05). The addition of chIL-2 loaded MP improved challenge virus clearance from the BF as demonstrated by lower neutralizing antibody titers and reduced IL-4 and IFN-α mRNA expression in the bursa at 7 days postchallenge compared to the other challenged groups. Overall, the efficacy of the IBDV-DNA vaccine was improved by adsorption of the DNA vaccine onto cationic PLGA-MP, which also allowed mucosal application of the DNA vaccine.